Floating drug delivery systems: A review

Current Trends in Biotechnology and Pharmacy

Volumn 4, Issue 2, 2010, Pages 610-647

  Katakam, Vinay Kumar ^a   Somagoni, Jagan Mohan ^a   Reddy, Sunil ^a   Eaga, Chandra Mohan ^a   Rallabandi, Bala Ramesha Chary ^a   Yamsani, Madhusudan Rao ^a  

^a KAKATIYA UNIVERSITY   (India)

Author keywords

Evaluation in vitro and in vivo; Floating drug delivery systems (FDDS); Gastric residence time (GRT); Multiple units; Single unit

Indexed keywords

ACETYLSALICYLIC ACID; ALENDRONIC ACID; ALGINIC ACID; BETA LACTAM ANTIBIOTIC; CAPTOPRIL; CARBOMER; CHLOROTHIAZIDE; CHLORPHENIRAMINE MALEATE; CIPROFLOXACIN; DICLOFENAC; EUDRAGIT; FUROSEMIDE; HYDROXYPROPYLMETHYLCELLULOSE; IBUPROFEN; INDOMETACIN; KETOPROFEN; MACROGOL; MELATONIN; MELOXICAM; MICROSPHERE; NIMODIPINE; OFLOXACIN; POVIDONE; RIBOFLAVIN; SOTALOL; TERFENADINE; THEOPHYLLINE; TRANILAST; UNINDEXED DRUG; VERAPAMIL;

DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG FORMULATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG RELEASE; DRUG RETENTION; DRUG TRANSPORT; EFFERVESCENT TABLET; FLOATING DRUG DELIVERY SYSTEM; GASTROINTESTINAL TRACT; GEL; HUMAN; HYDRODYNAMICS; NONHUMAN; REVIEW; SINGLE DRUG DOSE; STOMACH PH; STOMACH SECRETION;

EID: 77951671612     PISSN: 09738916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (128)

1. Chawla, G., Gupta P., Koradia, V. and Bansal, A. K. (2003). Gastro retention: A means to address regional variability in intestinal drug absorption. Pharm.Tech., 50-68
2. Rouge, N., Buri, P. and Doelkar, E. (1996). Drug absorption site in gastrointestinal tract and dosage forms for site specific delivery. Int.J.Pharm, 136(1): 117-139
3. Hirtz, J. (1985).The GIT absorption of drugs in man: a review of current concepts and methods of investigation. Br J Clin Pharmacol.; 19: 77S-83S
4. Ponchel, G. and Irache, J.M. (1998). Specific and non-specific bioadhesive particulate system for oral delivery to the gastrointestinal tract. Adv Drug Del Rev., 34: 191-219
5. Lenaerts, V.M. and Gurny, R. (1990). Gastrointestinal Tract- Physiological variables affecting the performance of oral sustained release dosage forms. In: Lenaerts V, Gurny R, eds. Bioadhesive Drug Delivery System. Boca Raton, FL: CRC Press
6. Deshpande, A.A., Shah, N. H., Rhodes, CT. and Malick, W. (1997). Development of a novel controlled-release system for gastric retention. PharmRes 14:815-819 PubMed DOI: 10.1023/A: 1012171010492
7. Rednick, A.B. and Tucker, S.J. (1970) Sustained release bolus for animal husbandry. US patent 3 507 952
8. Davis, S.S., Stockwell, A.F. and Taylor, M.J.(1986). The effect of density on the gastric emptying of single and multiple unit dosage forms. PharmRes., 3: 208-213
9. Urguhart, J. and Theeuwes, F. (1994). Drug delivery system comprising a reservoir containing a plurality of tiny pills. US patent 4 434 153
10. Mamajek, RC and Moyer, ES. (1980).Drug dispensing device and method. US Patent 4 207 890
11. Fix, J.A., Cargill, R. and Engle, K. (1993). Controlled gastric emptying. III. Gastric residence time of a non-disintegrating geometric shape in human volunteers. Pharm Res., 10:1087-1089
12. Kedzierewicz, F., Thouvenot, P., Lemut, J., Etienne, A., Hoffman, M. and Maincent, P. (1999). Evaluation of peroral silicone dosage forms in humans by gamma- scintigraphy. J. Control Release., 58:195-205
13. Groning, R. and Heun, G. (1984). Oral dosage forms with controlled gastrointestinal transit. Drug Dev Ind Pharm., 10: 527-539
14. Groning, R. and Heun, G. (1989). Dosage forms with controlled gastrointestinal passage studies on the absorption of nitrofurantion. Int J Pharm., 56: 111-116
15. Desai, S. (1984). A Novel Floating Controlled Release Drug Delivery System Based on a Dried Gel Matrix Network [master's thesis]. Jamaica, NY: St John's University;
16. Vantrappen, G.R., Peeters, TL. and Janssens, J. (1979). The secretory component of interdigestive migratory motor complex in man. Scand J Gastroenterol., 14:663-667
17. Wilson, C.G. and Washington, N. (1989). The stomach: its role in oral drug delivery. In: Rubinstein MH, ed. Physiological Pharmacetical: Biological Barriers to Drug Absorption. Chichester, UK: Ellis Horwood., 47-70
18. Desai, S. and Bolton, S. (1993). A floating controlled release drug delivery system: in vitro- in vivo evaluation. Pharm Res., 10:1321-1325
19. Dressman, J.B., Berardi, R.R., Dermentzoglou, L.C., Russell, T.L., Schmaltz, S.P., Barnett, J.L. and Jarvenpaa, K.M. (1990).Upper gastrointestinal (GI) pH in young, healthy men and women. Pharm. Res., 7: 756-761
20. Russell, T.L., Berardi, R.R., Barnett, J.L., Dermentzoglou, L.C., Jarvenpaa, K.M., Schmaltz, S.P. and Dressman, J.B. (1993). Upper gastrointestinal pH in seventy-nine healthy, elderly, North Americanmen and women. Pharm. Res., 10 (2): 187-196
21. Lui, C.Y., Amidon, G.L., Berardi, R.R., Fleisher, D., Youngberg, C. and Dressman, J.B. (1986) Comparison ofgastrointestinal pH in dog and humans: implications on the use of the beagle dog as a model for oral absorption in humans. J. Pharm. Sci., 75: 271-274
22. Mojaverian, P. and Chan, K.K.H. (1988). Radiotelemetric determination of gastrointestinal pH, in vitro accuracy and in vivo reproducibility in man. Pharm. Res., 5: S-243
23. B.S. Dave., A.F. Amin and M.M. Patel. (2004). "Gastroretentive drug delivery system of ranitidine hydrochloride formulation and in vitro evaluation", AAPS Pharm. Sci. Tech., 5(2): 1-6
24. Grubel, P. (1987). Gastric emptying of non- digestible solids in the fasted dog, J.Pharm.Sci., 76: 117-122
25. Clarke, M., Newton, J.M. and Short, M.D. (1993). Gastrointestinal transit of pellets of differing size and density, Int. J. Pharm., 100(1-3): 81-92
26. Singh, B.N. and Kim, K.H. (2000). "Floating Drug Delivery Systems: An Approach to Oral Controlled Drug Delivery via Gatric Retention," J.Controlled Rel.,63(1-2): 235-259
27. Cargil, R., Caldwell, L.J., Engle, K., Fix, J.A., Porter, P.A. and Gardner, C.R. (1998). Controlled Gastric Eptying. I. effects of physical propertie on gastric residence time of non disintegrating geometric shapes in begale dogs. Pharma. Re., 5 (8): 533-536
28. Gastro retentive drugs: a review, by Prahlad Tayade (3 Feb 2008). Pharma Pulse Express
29. Groves, M.J. (2001). Effect of FITC- dextran molecular weight on its release from floating cetyl alcohol and HPMC tablets, J. Pharm. Pharmacol., 53(1): 49-56
30. Wei, Z., Yu, Z. and Bi, D. (2001). Design and evaluation of a two-layer floating tablet for gastric retention using cisapride as a model drug, Drug Dev. Ind. Pharm., 27 (5): 469-474
31. Krogel, I. and Bodmeier, R. (1999). Floating or pulsatile drug delivery systems based on coated effervescent cores, Int. J. Pharm., 187 (2): 175-184
32. Ichikawa, M., Kato, T., Kawahara, M., Watanabe, S. and Kayano, M. (1991). A new multiple-unit oral floating dosage system: II. In vivo evaluation of floating and sustained-release characteristics with p- aminobenzoic acid and isosorbide dinitrate as model drugs, J. Pharm. Sci., 80 (12): 1153-1156
33. Washington, N. (1987). Investigation into the barrier action of an alginate gastric reflux suppressant, Liquid Gaviscon, Drug Investig., 23-30
34. Foldager, J., Toftkjor, H. and Kjornos, K. (1991). Antacid composition, US patent 506809,
35. Havelund, T., Aalykke, C. and Rasmussen, L. (1997). Efficacy of a pectin-based antireflux agent on acid reflux and recurrence of symptoms and oesophagitis in gastro-oesophageal reflux disease, Eur. J. Gastroenterol. Hepatol,. 9 (5): 509-514
36. Sato, Y., Kawashima, Y., Takeuchi, H., Yamamoto, H. and Fujibayashi, Y. (2004). Pharmaco scintigraphic evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans, J. Control. Release., 98 (1): 75-85
37. Streubel, A., Siepmann, J. and Bodmeier, R. (2002). Floating microparticles based on low density foam powder, Int. J. Pharm., 241 (2):279-292
38. Streubel, A., Siepmann, J. and Bodmeier, R. (2003). Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release, Eur. J. Pharm. Sci., 18 (1): 37-45
39. Reddy, L.H. and Murthy, R.S. (2002). Floating dosage systems in drug delivery, Crit. Rev. Ther. Drug Carr. Syst., 19 (6): 553-585.
40. S.J. Hwang, S.J. Park, H. and Park, K. (1998). Gastric retentive drug-delivery systems, Crit. Rev. Ther. Drug Carr. Syst., 15 (3): 243-284.
41. Dubernet, C. (2004). Syste'mes á libération gastrique prolongée, in: F. Falson- Rieg, V. Faivre, F. Pirot (Eds.). Nouvelles formes médicamenteuses, É ditions Médicales Internationales, É ditions TEC and DOC, Cachan, pp. 119-133.
42. Oth, M., Franz, M., Timmermans, J. and Moes, A. (1992). The bilayer floating capsule: a stomach-directed drug delivery system for misoprostol, Pharm. Res., 9 (3): 298-302.
43. Krogel, I. and Bodmeier, R. (1999). Development of a multifunctional matrix drug delivery system surrounded by an impermeable cylinder, J. Control. Release., 61 (1-2): 43-50.
44. Yang, L. and Fassihi, R. (1996). Zero order release kinetics from self correcting floatable configuration drug delivery system. J Pharm Sci., 85:170-173.
45. Soppimath, K.S., Kulkarni, A.R., Rudzinski, W.E. and Aminabhavi, T.M. (2001). Microspheres as floating drug delivery system to increase the gastric residence of drugs. Drug Metab. Rev., 33:149-160.
46. Ichikawa, M., Watanabe, S. and Miyake, Y. (1991). A new multiple unit oral floating dosage system. I: Prepration and in vitro evaluation of floating and sustained-release kinetics. J Pharm Sci., 80: 1062-1066.
47. Kolter (2003). Active ingredient containing floating forms comprising polyvinyl acetate and polyvinyl pyrrolidone, their use and production, US pat 6,635,279.
48. Watanabe, K., Machida, Y., Takayama, K., Iwata, M. and Nagai, T. (1993). Preparation and evaluation of intragastric floating tablet having pH independent buoyancy and sustained release property, Arch Pract Pharm., 53: 1-7
49. Rouge, N., Buri, P and Doelker, E. (1996). Drug absorption sites in the gastrointestinal tract and dosage forms for site- specific delivery, Int J Pharm., 136: 117-139
50. Burns, S J., Corness, D., Hay, G., Higginbottom, S., Whelan, I., Attwood, D. and Barnwell, S G. (1995). Development and validation of an in vitro dissolution method for a floating dosage form with biphasic release characteristics, Int J Pharm., 121: 37-44
51. Singh, R N. and Kim, K H. (2005). Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention, J Control Release, 63: 235-259
52. Gansbeke, BV., Timmermans, J., Schoutens, A and Moes, A J.(1991).Intragastric positioning of two concurrently ingested pharmaceutical matrix dosage forms, Nucl Med Biol, 18: 711-718
53. Horton, R E., Ross, F G M. and Darling, G H. (1965). Determination of the emptying- time of the stomach by use of enteric- coated barium granules, Br Med J, 1: 1537-1539
54. Jao, F., Edgren, D E. and Wong, P S. (2000). Gastric retention dosage form havin multiple layers., (July, 2006) Int Application WO0038650
55. Hendee, W R. (1994). In Textbook of Diagnostic Imaging II, vol 1, edited by C E Putman and C E Ravin (W B Saunders, Philadelphia), 1-6
56. Steingotter, A., Weishaupt, D., Kunz Mader, P., Legsfeld, K., Thumshirn, H M., Boesinger, P., Fried M and Schwizer, W. (2003). Magnetic resonance imaging for the in vivo evaluation of gastric retentive tablets., Pharm Res., 20
57. Timmermanns J. and Moes A. (1990). How well do floating dosage forms float? Int.J.Pharm., 62(3): 207-216
58. Timmermans, J., Gansbeke, V.B. and Moes A.J. (1989). Assessing by gamma scintigraphy the in vivo buoyancy of dosage forms having known size and floating force profiles as a function of time. Vol I. Proceedings of the 5th International Conference on Pharmacy Technology. Paris, France: APGI., 42-51
59. Babu, V.B.M. and Khar, R.K. (1990). In vitro and In vivo studies of sustained release floating dosage forms containing salbutamol sulphate. Pharmazie; 45: 268-270
60. Davis., S.S. (2005). Formulation Strategies for Absorption Window. DDT. 10,249,257
61. Davis, S.S., Illum, L. and Hinchcliffe (2001) M. Gastrointestinal transit of dosage forms in the pig. J. Pharm. Pharmacol., 53: 33-39
62. Hoffman, A., Stepensky, D., Lavy, E., Eyal, S., Klausner, E. and Friedman, M. (2004). 1 Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms. Int. J. Pharm., 277: 141-153
63. Ezra, A., Hoffman, A., Breuer, E., Alferiev, I.S., Monkkonen, J., El Hanany-Rozen, N., Weiss, G., Stepensky, D., Gati, I., Cohen, H., Tormalehto, S., Amidon, G.L. and Golomb, G. A. (2000). Peptide prodrug approach for improving bisphosphonate oral absorption. J. Med. Chem., 43: 3641-3652
64. Klausner, E.A., Lavy, E., Stepensky, D., Cserepes, E., Barta, M., Friedman, M. and Hoffman, A.(2003). Furosemide pharmacokinetics and pharmacodynamics following gastroretentive dosage form administration to healthy volunteers. J. Clin. Pharmacol, 43: 711-720
65. Hoffman, A. (1998). Pharmacodynamic aspects of sustained release preparations. Adv. Drug Deliv. Rev., 33: 185-199
66. Stepensky, D., Friedman, M., Raz, I. and Hoffman, A. (2002). Pharmacokinetic- pharmacodynamic analysis of the glucose- lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect. Drug Metab. Dispos., 30 (8): 861-868
67. Hwang, S.J., Park, H. and Park, K. (1998). "Gastric retentive drug delivery systems." Crit. Rev. Ther.Drug Carrier Syst., 15: 243-284
68. Klausner, E.A., Eyal, S., Lavy, E., Friedman, M. and Hoffman (2003). A.Novel Levodopa gastroretentive dosage form: in vivo evaluation in dogs. J. Controlled release., 88: 117-126
69. Erni, W. and Held, K. (1987). The hydro- dynamically balanced system: a novel principle of controlled drug release. Eur Neurol., 27: 215-275
70. Menon, A., Ritschel, W.A., Sakr. (1994). A. Development and evaluation of a monolithic floating dosage form for furosemide. J Pharm Sci., 83: 239-245
71. Oth, M., Franz, M., Timmermans, J. and Moes (1992). A. The bilayer floating capsule: a stomach directed drug delivery system for misoprostal. Pharm Res., 9: 298-302
72. Hoffman, A. (1998). Pharmacodynamic aspectas of sustained release preparation. Adv, Drug deliv. Rev., 33:185-199
73. Rouge, N., Allémann, E. and Gex-Fabry, M. (1998). Comparative pharmacokinetic study of a floating multiple unit capsule, a high density multiple unit capsule and an immediate release tablet containing 25 mg atenolol. Pharm Acta Helv., 73:81-87
74. Ravichandran Mahalingam, Bhaskara Jasti, Raj Birudaraj, Dimitrios Stefanidis, Robert Killion, Tom Alfredson, Pratap Anne and Xiaoling, Li (2009). Evaluation of Polyethylene Oxide Compacts as Gastroretentive Delivery Systems. AAPS PharmSciTech., Vol. 10, No. 1: 98-103
75. Karunakar Neelam, Ravichandran Mahalingam, Raj Birudaraj, Tom Alfredson, Pratap Anne, Xiaoling Li and Bhaskara R. Jasti1. (2009). Relative Bioavailability of Chlorothiazide from Mucoadhesive Compacts in Pigs. AAPS PharmSciTech, Vol. 10, No. 4: 1331-1335
76. Lingam Meka., Bhaskar Kesavan., Krishna Mohan Chinnala., Venkateswarlu Vobalabonia and Madhusudan Rao Yamasani (2008). Preparation of matrix type multiple-unit Gastru Retentive Floating drug delivery system for Captopril based on gas formation technique: In vitro Evaluation. AAPS Pharm scitech, vol.9, No. 2; 612-619
77. Lingam Meka, Thadisetty Ashok, Venka teswarlu Vobalabonia and Madhusudan Rao Yamasani (2008). Design and evaluation of a Novel Matrix Type Multiple Units as Biphasic gastroretentive Drug Delivery systems; AAPS Pharm Scitech, vol.9, No. 4: 1253-1261
78. Lingam Meka, Bhaskar Kesavan, Venkatasimhadri Naidu Kalamata, Chandra Mohan Eaga, Suresh Bandari, Venka teswarlu Vobalabonia and Madhusudan Rao Yamasani (2009). Design and evaluation of Polymeric coated Minitablets as multiple Unit Gastroretentive Floating Drug Delivery systems for Furosemide. J of Pharamaceutical sciences, Vol. 98: 2122-2132
79. Basak, S.C., Rahman, J. and Ramalingam, M. (2007). Design and in vitro testing of a floatable gastroretentive gastroretentive tablet of metformin hydrochloride. Pharmazie.,62:145-148
80. Jaimini, M., Rana, A.C. and Tanwar, Y.S. (2007). Formulation and evaluation of famotidine floating tablet. Curr Drug Deliv., 4(1): 51-55
81. Badve, S.S., Sher, Korde, A. and Pawar (2007). AP. Development of hollow/porous calcium pectinitebeads for floating- pulsatiledrug delivery. Eur. J. Pharm. Biopharm., 65: 85-93
82. Chavanpatil, M.D., Jain, P., Chaudhari S., Shear, R., Vavia, P.R. (2006). Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin. Int. J. Pharm., 316: 86-92
83. Rahman, Z., Ali, M. and Khar, R.K. (2006). Design and evaluation of bilayer floating tablets of captopril. Acta Pharm., 56: 49-57
84. Xiaoqiang, Xu., Minije, S., Feng, Z. and Yiqiao, Hu (2006). Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: In vitro and in vivo evaluation in healthy volunteers. Int J Pharm., 310:139-145
85. Sharma, S. and Pawarm, A. (2006). Low density multiparticulate system for pulsatile release of meloxicam. Int J Pharm., 313: 150-158
86. Srivastava, A.K., Ridhurkar, D.N. and Wadhwa, S. (2005). Floating microspheres of cimetidine: formulation, characterization and in vitro evaluation. Acta. Pharm., 55: 277-285
87. Chavanpatil, M., Jain, P., Chaudhari, S., Shear, R. and Vavia P. (2005). Development of sustained release gastroretentive drug delivery system for ofloxacin: in vitro and in vivo evaluation. Int J Pharm., 304: 178-184
88. Jain, S.K., Awasthi, A.M., Jain, N.K., Agarwal, G.P. (2005). Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vivo evaluation. J. Control. Release., 107: 300-309
89. Patel, V.F., Patel, N.M. and Yeole, P.G. (2005). Studies on formulation andevaluation of ranitidine floating tablets. Indian J. Pharm. Sci., 67(6): 703-709
90. Muthusamy, K., Govindarajan, G. and Ravi, T K. (2005). Preparation and Evaluation of Lansoprazole Floating Micropellets. Indian J. Pharm. Sci., 67(1): 75-79
91. Dave, B.S., Amin, A.F. and Patel, M.M. (2004). Gastroretentive Drug Delivery System of Ranitidine hydrochloride: formulation and invitro evaluation. AAPS Pharm. Sci. Tech., 5(2): article 34
92. Sato, Y., Kawashima, Y., Takeuchi, H. and Yamamoto, H. (2004). In- vitro and in vivo Evaluation of riboflavin- containing microballons for a Floating controlled drug delivery system in healthy humans. Int. J. Pharm., 275: 97-107
93. Umamaheshwari, R.B., Jain, S., Bhadra, D. and Jain, N.K. (2003). Floating Microsphers bearing acetohydroxamic acid for the treatment of Helicobacter pylori. J Pharm, Pharmacol, 55(12): 1607-1613
94. El-Gibaly (2002). Development and Invitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non floating chitosan microspheres. Int. J. Pharm., 249: 7-21
95. Blaser M.J. (1992). Hypothesis on the pathogenesis and natural history of Helicobacter pylori induced inflammation. Gastroenterology., 102: 720-727
96. Katayama, H., Nishimura, T., Ochi, S., Tsuruta, Y. and Yamazaki, Y. (1999). Sustained release liquid preparation using sodium alginate for eradication of Helicobacter pylori. Biol Pharm Bull., 22:55-60
97. Gibaly, E.I. (2002). Development and evaluation of novel floating chitosan microcapsules: comparision with non floating chitosan microspheres. Int J Pharm., 249: 39-47
98. Sato, Y. and Kawashima, Y. (2003). In vitro and in vivo evaluation of riboflavin containing microballoons for a floating controlled drug delivery system in healthy human volunteers. J Control Release., 93: 39-47
99. Shimpi, S., Chauhan, B., Mahadik, K.R. and Paradkar, A. (2004). Preparation and evaluation of diltiazem hydrochloride- Gelucire 43/01 floating granules prepared by melt granulation. AAPS PharmSciTech., 5:E43
100. Dave, B.S., Amin, A.F. and Patel, M.M. (2004). Gastro retentive drug delivery system of ranitidine hydrochloride: formulation and in vitro evaluation. AAPS PharmSciTech., 5:E34
101. Sriamornsak, P., Thirawong, N. and Puttipipatkhachorn, S. (2004). Morphology and buoyancy of oil-entrapped calcium pectinate gel beads. The AAPS Journal, 6:E24
102. Ichikawa, M., Watanabe, S. and Miyake, Y. (1989). Inventors. Granule remaining in stomach. US patent 4 844 905. July 4
103. Yang, L., Esharghi, J. and Fassihi, R. (1999). A new intra gastric delivery system for the treatment of helicobacter pylori associated gastric ulcers: in vitro evaluation. J Control Release., 57:215-222
104. Ozdemir, N., Ordu, S. and Ozkan, Y. (2000). Studies of floating dosage forms of furosemide: in vitro and in vivo evaluation of bilayer tablet formulation. Drug Dev Ind Pharm., 26:857-866
105. Choi, BY., Park, H.J., Hwang, S.J. and Park, J.B. (2002). Preparation of alginate beads for floating drug delivery: effects of CO2 gas forming agents. Int J Pharm., 239:81-91
106. Li, S., Lin, S., Daggy, B.P., Mirchandani, H.L. and Chien, T.W. (2002). Effect of formulation variables on the floating properties of gastric floating drug delivery system. Drug Dev Ind Pharm., 28: 783-793
107. Li, S., Lin, S., Chien, T.W., Daggy, B.P. and Mirchandani, H.L. (2001). Statistical optimization of gastric floating system for oral controlled delivery of calcium. AAPSPharmSciTech., 2:E1
108. Fassihi, R. and Yang, L. (1998). Inventors. Controlled release drug delivery systems. US patent 5 783 212
109. Talwar, N., Sen, H. and Staniforth, J.N., (2001). Inventors. Orally administered controlled drug delivery system providing temporal and spatial control. US patent 6 261 601
110. Michaels, A.S., Bashwa, J.D. and Zaffaroni, A. (1975). Inventors. Integrated device for administering beneficial drug at programmed rate. US patent 3 901 232
111. Michaels, A.S. (1974). Inventor. Drug delivery device with self actuated mechanism for retaining device in selected area. US patent 3 786 813
112. Baumgartner, S., Kristel, J., Vreer, F., Vodopivec, P. and Zorko, B. (2000). Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int J Pharm.; 195:125-135
113. Moursy, N.M., Afifi, N.N., Ghorab, D.M. and El-Saharty, Y. (2003). Formulation and evaluation of sustained release floating capsules of Nicardipine hydro-chloride. Pharmazie., 58:38-43
114. Atyabi, F., Sharma, H.L., Mohammed, H.A.H. and Fell, J.T. (1996). In vivo evaluation of a novel gastro retentive formulation based on ion exchange resins. J Control Release., 42:105-113
115. Thanoo, B.C., Sunny, M.C. and Jayakrishnan, A. (1993). Oral sustained release drug delivery systems using polycarbonate microspheres capable of floating on the gastric fluids. J Pharm Pharmacol., 45:21-24
116. Nur, A.O. and Zhang, J.S. (2000). Captopril floating and/or bioadhesive tablets: design and release kinetics. Drug Dev Ind Pharm., 26:965-969
117. Bulgarelli, E., Forni, F. and Bernabei, M.T. (2000). Effect of matrix composition and process conditions on casein gelatin beads floating properties. Int J Pharm., 198:157-165
118. Whitehead, L., Collett, J.H. and Fell, J.T. (2000). Amoxycillin release from a floating dosage form based on alginates. Int J Pharm., 210:45-49
119. Asmussen, B., Cremer, K., Hoffmann, H.R., Ludwig, K. and Roreger, M. (2001). Inventors Expandable gastrore-tentive therapeutic system with controlled active substance release in gastrointestinal tract. US patent 6 290 989
120. El-Kamel, A.H., Sokar, M.S, A, Gamal, and Naggar, V.F. (2001). Preparation and evaluation of ketoprofen floating oral drug delivery system. Int J Pharm., 220:13-21
121. Illum, L. and Ping, H. (2001). Inventors. Gastroretentive controlled release microspheres for improved drug delivery. US patent 6 207 197
122. Sheth, P.R. and Tossounian, J.L. (1979). Inventors. Novel sustained release tablet formulations. 4 167 558
123. Spickett, R.G.W., Vidal, J.L.F. and Escoi, J.C. (1993). Inventors. Antacid preparation having prolonged gastric residence. US patent 5,288,506
124. Franz, M.R. and Oth, M.P.(1993). Inventors. Sustained release, bilayer buoyant dosage form. US patent 5 232 704
125. Wu, W., Zhou, Q., Zhang, H.B, Ma G.D. and Fu C.D. (1997). Studies on nimodipine sustained release tablet capable of floating on gastric fluids with prolonged gastric resident time. Yao Xue Xue Bao., 32:786-790
126. Wong, P.S.L., Dong, L.C., Edgren, D.E. and Theeuwes, F. (2000) Inventors. Prolonged release active agent dosage form adapted for gastric retention. US patent 6 120 803
127. Yang, L., Esharghi, J. and Fassihi, R. (1999). A new intra gastric delivery system for the treatment of helicobacter pylori associated gastric ulcers: in vitro evaluation. J Control Release., 57:215-222
128. Drug delivery Technology. (2008). Volume 8., No 2: 24-26 (February, 2008).